JULIAN ARIZA: Open Payments
NPI 1053520262 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 16 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $123 |
| ABBVIE INC. | 4 | $81 |
| Axsome Therapeutics, Inc. | 2 | $65 |
| Corium, LLC | 2 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: CAPLYTA, VRAYLAR, Auvelity, Azstarys, TRINTELLIX, REXULTI, SPRAVATO.
Industry payments across FL — which companies pay providers there.
